An MUSC Hollings Cancer Center research team has created what team members believe to be among the first small molecules designed to stimulate immune cells to fight cancer. More importantly, these compounds inhibit a specific enzyme that hasn’t been targeted with small molecules for the treatment of cancer.
Click here for original story, Researchers develop small molecule to stimulate natural killer cells against neuroblastoma
Source: Phys.org